Attendee Package 0.00 (USD)
This Package provides access to the entire event
Start Date:7/17/2023
Start Time:8:00 AM EDT
Duration:60 minutes
If you're already registered for the Acumen Pharmaceuticals: Conference Call to Discuss Results of Acumen’s Phase 1 INTERCEPT-AD Trial webcast, click below:
Daniel O’Connell
Chief Executive Officer
Acumen
Eric Siemers, MD
Chief Medical Officer
Matt Zuga
Chief Financial Officer
Steven DeKosky, MD
Deputy Director
McKnight Brain Institute at the University of Florida
Lawrence Honig, MD, PhD
Director
New York State Center of Excellence for Alzheimer's Disease at Columbia